Boston Scientific Corp Stock Buy Hold or Sell Recommendation
| BSX Stock | USD 97.16 1.79 1.88% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Boston Scientific Corp is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Boston Scientific Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Boston Scientific Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Boston Scientific Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Boston and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Boston |
Execute Boston Scientific Buy or Sell Advice
The Boston recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Boston Scientific Corp. Macroaxis does not own or have any residual interests in Boston Scientific Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Boston Scientific's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Boston Scientific Trading Alerts and Improvement Suggestions
| Boston Scientific is unlikely to experience financial distress in the next 2 years | |
| Boston Scientific has a very strong financial position based on the latest SEC filings | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Tredje AP fonden Cuts Stock Holdings in Boston Scientific Co. |
Boston Scientific Returns Distribution Density
The distribution of Boston Scientific's historical returns is an attempt to chart the uncertainty of Boston Scientific's future price movements. The chart of the probability distribution of Boston Scientific daily returns describes the distribution of returns around its average expected value. We use Boston Scientific Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Boston Scientific returns is essential to provide solid investment advice for Boston Scientific.
| Mean Return | 0.13 | Value At Risk | -2.65 | Potential Upside | 1.88 | Standard Deviation | 1.44 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Boston Scientific historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Boston Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Boston Scientific, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Boston Scientific Corp back and forth among themselves.
| Shares | Bollard Group Llc | 2024-12-31 | 20.7 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 20.5 M | Norges Bank | 2024-12-31 | 19.7 M | Massachusetts Financial Services Company | 2024-12-31 | 19.7 M | Franklin Resources Inc | 2024-12-31 | 16.5 M | Amvescap Plc. | 2024-12-31 | 15.8 M | Hhg Plc | 2024-12-31 | 15 M | Northern Trust Corp | 2024-12-31 | 14.6 M | Goldman Sachs Group Inc | 2024-12-31 | 12.9 M | Blackrock Inc | 2024-12-31 | 139 M | Vanguard Group Inc | 2024-12-31 | 132.9 M |
Boston Scientific Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (65M) | (346M) | (321M) | (660M) | (228M) | (216.6M) | |
| Change In Cash | 1.4B | 173M | (1.0B) | (71M) | (449M) | (426.6M) | |
| Free Cash Flow | 1.1B | 1.3B | 914M | 1.7B | 2.6B | 2.8B | |
| Depreciation | 1.1B | 1.1B | 1.1B | 1.2B | 1.3B | 1.3B | |
| Other Non Cash Items | 337M | 17M | 540M | 253M | 54M | 51.3M | |
| Net Income | (82M) | 1.0B | 698M | 1.6B | 1.8B | 1.9B | |
| End Period Cash Flow | 2.0B | 2.2B | 1.1B | 1.1B | 606M | 673.6M | |
| Investments | (146M) | 15M | 56M | (1.7B) | (5.7B) | (5.4B) | |
| Change Receivables | (130M) | 335M | (279M) | (220M) | (198M) | (188.1M) | |
| Net Borrowings | 1.4B | 2.8B | (999M) | (165M) | (189.8M) | (180.3M) | |
| Change To Netincome | 312M | 205M | 100M | 410M | 369M | 516.1M |
Boston Scientific Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Boston Scientific or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Boston Scientific's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Boston stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | 0.78 | |
σ | Overall volatility | 1.48 | |
Ir | Information ratio | 0.16 |
Boston Scientific Volatility Alert
Boston Scientific Corp has relatively low volatility with skewness of -0.82 and kurtosis of 3.3. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Boston Scientific's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Boston Scientific's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Boston Scientific Fundamentals Vs Peers
Comparing Boston Scientific's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Boston Scientific's direct or indirect competition across all of the common fundamentals between Boston Scientific and the related equities. This way, we can detect undervalued stocks with similar characteristics as Boston Scientific or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Boston Scientific's fundamental indicators could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Boston Scientific to competition |
| Fundamentals | Boston Scientific | Peer Average |
| Return On Equity | 0.0889 | -0.31 |
| Return On Asset | 0.0504 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | 0.17 % | (5.51) % |
| Current Valuation | 154.12 B | 16.62 B |
| Shares Outstanding | 1.48 B | 571.82 M |
| Shares Owned By Insiders | 0.19 % | 10.09 % |
| Shares Owned By Institutions | 93.26 % | 39.21 % |
| Number Of Shares Shorted | 12.87 M | 4.71 M |
| Price To Earning | 107.05 X | 28.72 X |
| Price To Book | 6.59 X | 9.51 X |
| Price To Sales | 8.56 X | 11.42 X |
| Revenue | 16.75 B | 9.43 B |
| Gross Profit | 11.46 B | 27.38 B |
| EBITDA | 2.6 B | 3.9 B |
| Net Income | 1.85 B | 570.98 M |
| Cash And Equivalents | 928 M | 2.7 B |
| Cash Per Share | 0.24 X | 5.01 X |
| Total Debt | 10.75 B | 5.32 B |
| Debt To Equity | 0.51 % | 48.70 % |
| Current Ratio | 1.45 X | 2.16 X |
| Book Value Per Share | 14.76 X | 1.93 K |
| Cash Flow From Operations | 3.44 B | 971.22 M |
| Short Ratio | 1.82 X | 4.00 X |
| Earnings Per Share | 1.25 X | 3.12 X |
| Price To Earnings To Growth | 1.91 X | 4.89 X |
| Target Price | 115.62 | |
| Number Of Employees | 53 K | 18.84 K |
| Beta | 0.77 | -0.15 |
| Market Capitalization | 143.39 B | 19.03 B |
| Total Asset | 39.4 B | 29.47 B |
| Retained Earnings | 2.67 B | 9.33 B |
| Working Capital | 521 M | 1.48 B |
Note: Acquisition by Joseph Fitzgerald of 60 shares of Boston Scientific subject to Rule 16b-3 [view details]
Boston Scientific Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Boston . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Boston Scientific Buy or Sell Advice
When is the right time to buy or sell Boston Scientific Corp? Buying financial instruments such as Boston Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Boston Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.